Barigen 4 mg (Baricitinib): An Overview
Barigen 4 mg is a pharmaceutical formulation of Baricitinib, a Janus kinase (JAK) inhibitor. It is primarily used to manage and treat conditions characterized by inflammation and immune dysregulation. This medication has gained prominence for its efficacy in treating autoimmune disorders and has also shown significant promise in addressing severe c